is producing the asters anika vaccine in very few countries so we need to look at where we can up the production capacity so i'm in clark in reading is this just political point scoring but it does seem to be a. critical point scoring yes i mean you have to ask yourself are. efforts to discredit the senate does that seem insensitive if if if the state safety why it's parts of europe is it came to get over it the germans for instance. looking to. tell you know what seem pretty they're going to the russians so it does seem a bit all right it does cooper in delhi from where you are is this a particularly acute issue in as much as there are issues of procurement and procurement specifically in india because you are going through a vicious 2nd wave of coronavirus there. yes it's a quite led set of issues as fires india's vantage point goes the 1st is that beginning crew india expanded the vaccination program so those 45 years and above and then beginning me in a more recent recession it's open door than dolls and that's 18 years and above which has obviously led to an enormous increase in

more down our your johnson and johnson that scene for those younger age groups that are then asters anika and you know like in spain where i am now they have limited yesterday to get used to those age 60 to 64 so they'll use up the vaccines they have built in the finished the 2nd doses for that as you have only received one dose and then that will be more than scenes and for the rest of the well what i'm hoping is that we can turn this around and say given that the european medicines agency has said it's safe we can use this to accelerate next ation programs in other parts of the world which is extremely important in order to avoid variance of concerns as as variants flourish leave risk that some of them may become resistant to the axioms chris when you have a you chasing 400000000 doses of. the americans 300000000 in the past trying to. be ready for the eventuality of starting the fast track vaccination campaign what would be the reaction do you think among the decision makers now against the backdrop of the findings of the ema. well i hope they'll look at the statistics and the statisti

they have been some supply issues in april in pots used to supply issues from the india of yesterday anika vaccine but said the u.k. government has been clay that that is something that will affect the doses in april and they're optimistic going forward that particularly keen to stress that people 2nd doses will be protected will be available we know in the u.k. of course that doses all that and 2nd dose a 12 week spots they send that to those they says would be affected but withhold the bowl out will continue with plans and what about the british a travel industry a smudge just like in the rest of the world really took a beating will this progress in opening up the country help each recover well of course that's a hope but any decisions that are made now going forward authorities here will have to weigh out very kathy the risk benefit facts of the benefits of international tourism resuming and the risk of any new variants coming into the country that could undermine the vaccine program here zoraida china chills impale there in london thank you so much. well here in europe there are still

unishe and you have a veil and the vaccine we have available now is the esters anika vaccine i would use it because the risk from coated is so high. you know we know that the german chancellor she's going to get the vaccine tomorrow her 1st shot that's the picture here in europe now let's compare that with how dr fallon she sees the situation at the moment where you are in the u.s. take a listen we are in a race between vaccinating as many people as quickly and as expeditiously as we possibly can and the threat of the resurgence of viruses in our country because as we know we're at a precarious situation with many states having increases in the daily number of cases and that does have a we can hear the worry in his voice and yet at the same time the united states is vaccinating what is it around 3000000 people every day so what is the situation well as tony says it is indeed a race a race between how quickly we can vaccinate and how quickly this virus can spread at the moment the virus is ed and here in the united states throughout most of the country you know the beepers the people

and the now what the european medical agency is saying is that look the benefits of a master's anika vaccine are way the risks and what they mean by that is the risks of covert 19 to most people far higher than the risks or than astra zeneca jab nevertheless they have found that there is a link between the astra zeneca jab and some very unusual forms of blood clots even though they are extremely rare and that point was made by both by the european medical agency and the u.k. a regulator nevertheless the european medical agency said that all health workers and the public should be aware of these risks even if they are very rare they should know that when they've had their job they should look out for any symptoms that could raise the alarm as in the weeks after they have their 1st or 2nd dose that these side effects should be listed as such for people going to get an ice pick a jab but the message is from the e.u. look it is in a way business as usual that this astra zeneca vaccine must continue to be used especially in the european union we're seeing many countries battling a 3rd wav

what do people in france make of that well as in other european countries skepticism of the asters anika vaccine is high 60 percent of the french are really skeptical of that vaccine but however if you look at when you look at the figures of the vaccination campaign over the past few days and weeks actually it has better sped up quite a bit at this very moment in time 8500000 people here in the country have received a 1st jab and over the past few days the speed of the vaccination campaign was at 200 or 300008 day that's quite fast the government said has said that they will keep on going like that and it looks like for now at least the skepticism of the astra zeneca jap hasn't had an impact on the speed of the vaccination campaign just yet lisa lewis in paris thank you. meantime in germany there is widespread concern that a complete lockdown will also be necessary to get on top of rising coated 1000 infections medical authorities say that hospital's intensive care facilities are coming under increasing pressure the leader of chancellor angela merkel c.d.u. party says political leaders w

director also spoke a it's about a sounds just anika and concerns over those potential links to blood clots catherine saw tells us more. he did say that they still recommend that african countries continue using this vaccine because. benefits greatly outweigh the risks and it's important to note that most of the african countries are using astra zeneca then the issue of this shift from procuring astra zeneca from the seram instituted in india to johnson and johnson came up and he said that last week the african union signed a deal with johnson and johnson to secure a 400000000 doses of vaccine in the 3rd quarter of the year but he said this is in no way linked to the concerns in the problems that are being seen with astra zeneca he said that the program is that ika vaccines will still continue being distributed on the continent through the call of the program but what is happening is that the african union wants to. secure more and more scenes from different quarters wants to sign more bilateral deals because this is all complimentary he says that they want to get in as many vaccines

vaccines it's accuse the company of breaching its contract to supply enough jobs for the brooke astor's anika says the legal action is without merit and that it has complied with the agreement potential partners in paris with more on why the european union is making this move. they might be wanting to put more pressure on the british swedish pharmaceutical company to speed up the delivery of its doses they've also come under quite a bit of a criticism from eve member states for the slow vaccine rollout in the e.u. which is a seen very much as being the e.u. commission's responsibility the commission saying that that slow rollout was in part due to the fact that they just didn't have enough astra zeneca doses at least not the ones that they said they were promised 30000000 doses of astra zeneca were delivered by the company in the 1st quarter the year that's far short of the 120000000 doses that the e.u. commission say were promised under the contract that it sides with astra zeneca now that is why they're launching this legal action the u. commission says that astra zeneca simply breached its

say they are still confident and asked as anika as code the 1000 vaccine and its effectiveness even after finding it may cause blood clotting in very rare cases the risks could be greater amongst younger people fronting some governments to restrict or advise against its use in the age groups john howard ports now from london. the oxford astra zeneca vaccine uncomfortable scrutiny medicines regulators in the u.k. and the e.u. have judged that its benefits outweigh any possible risks but they haven't ruled out a causal link between the vaccine and rare blood clot conditions in a tiny number of recipients based on the current evidence the benefits of the covert 900 faxon astra zeneca against covert 90 and its associated risks hospitalization and death continues to outweigh the risks for the vast majority of people. our review has reinforced that the risk of this fred suspected side effect remains extremely small in arms today the european medicines agency said there was insufficient data to isolate risk factors like age and gender and that blood clotting should be listed as a possible side e

covert 19 let's take a look at some of the developments in the pandemic france is to offer yesterday anika vaccine to anyone over 55 starting next week other european countries have restricted the astra zeneca jab to older people because of fears over side effects libya has started its long delayed vaccination campaign the prime minister was given his shot on television and the us supreme court has ruled that california cannot use coronavirus restrictions to limit religious gatherings in private homes for britain is mourning prince philip the husband to queen elizabeth the 2nd his funeral will take place in a week's time at windsor castle the prince served in the royal navy and the military led the tributes to his long life of public service. gun salutes run down to cross the united kingdom in honor of prince philip who died on friday if you age of $99.00 from each barracks in london. counseling belfast. cardiff council. and edinburgh castle. all 4 corners of the nation press the pause button for a short while to remember the prince who also held the title of the queue of edinburgh gun sal

joins us now live from the you will break katherine was behind this decision to switch your master's anika to johnson and johnson then. well the issue of these vaccinations came up in the weekly briefing by the africa c.d.c. and the director was asked a question about astra zeneca and you know reports from regulators of the e.u. and the u.k. that you know issues with blood clots and that this are rare side effects so it was asked to recommend what african countries should do and he said that yes there is this issue but also because the benefits greatly outweigh the risks he recommends or c.d.c. africa recommends that african countries continue to use this vaccination those also the question that you raised in the introduction about the use the procurement of astra zeneca he said that the african union is now has signed a deal with to 'd procure 400000000 doses of johnson and johnson by the 3rd quarter of this year but he was very clear and wanted to clarify the reason for this he said it's not because of the issues that have been raised about astra zeneca but it's also it's because of deep

countries don't have access to any vaccines at all and so i think they would welcome access to yesterday's anika vaccine particularly when they've heard that the european medicines agency has said it's safe so i think some countries are shaking their heads and saying well if the europeans won't use it send it to us because sooner you know at some point they're going to need to vaccines anyway so why don't we get it to them if countries decide that they're not going to use it the important thing is to make sure that they're not sitting on the vaccines that they get them to countries where they will be administered remind us of the scale of this and that in terms of the risk how would you describe it. the risk of side effects. i mean there's been around 200 reported cases of blood clots in around 34000000 people so that's that's an extremely rare occurrence and as mentioned earlier in the program it means that pharmacovigilance in the surveillance in europe and in the u.k. in the european union is working well so there detecting when there are side effects in there and they're investigating them b